Association of SARS-CoV‑2 and Polypharmacy with Gut–Lung Axis: From Pathogenesis to Treatment

• Jonaid Ahmad Malik,
• Sakeel Ahmed,
• Zahid Yaseen,
• Muteb Alanazi,
• Tareq Nafea Alharby,
• Hisham Abdulaziz Alshammari,
• Sirajudheen Anwar

Affiliations

Jonaid Ahmad Malik

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Guwahati, Assam, India

Sakeel Ahmed

Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Ahmedabad, Gujarat, India

Zahid Yaseen

Department of Pharmaceutical Biotechnology, Delhi Pharmaceutical Sciences and Research University, New Delhi, Delhi, India

Muteb Alanazi

Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia

Tareq Nafea Alharby

Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia

Hisham Abdulaziz Alshammari

Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia

Sirajudheen Anwar

Department of Pharmacology and Toxicology, College of Pharmacy, University of Hail, Hail, Saudi Arabia